IL99497A - Synergistic compositions comprising tnf and il-4 - Google Patents

Synergistic compositions comprising tnf and il-4

Info

Publication number
IL99497A
IL99497A IL99497A IL9949791A IL99497A IL 99497 A IL99497 A IL 99497A IL 99497 A IL99497 A IL 99497A IL 9949791 A IL9949791 A IL 9949791A IL 99497 A IL99497 A IL 99497A
Authority
IL
Israel
Prior art keywords
tnf
synergistic compositions
tumor
lymphotoxin
interleukin
Prior art date
Application number
IL99497A
Other languages
English (en)
Other versions
IL99497A0 (en
Original Assignee
Res Dev Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Dev Foundation filed Critical Res Dev Foundation
Publication of IL99497A0 publication Critical patent/IL99497A0/xx
Publication of IL99497A publication Critical patent/IL99497A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2026—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Output Control And Ontrol Of Special Type Engine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Liquid Crystal Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL99497A 1990-10-01 1991-09-16 Synergistic compositions comprising tnf and il-4 IL99497A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US59097790A 1990-10-01 1990-10-01

Publications (2)

Publication Number Publication Date
IL99497A0 IL99497A0 (en) 1992-08-18
IL99497A true IL99497A (en) 1997-03-18

Family

ID=24364509

Family Applications (1)

Application Number Title Priority Date Filing Date
IL99497A IL99497A (en) 1990-10-01 1991-09-16 Synergistic compositions comprising tnf and il-4

Country Status (21)

Country Link
EP (1) EP0563060B1 (es)
JP (1) JP3226918B2 (es)
KR (1) KR100225322B1 (es)
CN (1) CN1053838C (es)
AT (1) ATE179617T1 (es)
AU (1) AU658588B2 (es)
CA (1) CA2092914C (es)
DE (1) DE69131202T2 (es)
DK (1) DK0563060T3 (es)
ES (1) ES2134200T3 (es)
FI (1) FI931426A7 (es)
GR (1) GR3030930T3 (es)
IE (1) IE913264A1 (es)
IL (1) IL99497A (es)
NO (1) NO931139L (es)
NZ (1) NZ239829A (es)
PT (1) PT99123B (es)
RU (1) RU2114633C1 (es)
SA (1) SA92120509B1 (es)
WO (1) WO1992005805A1 (es)
ZA (1) ZA917424B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995015177A2 (en) * 1993-12-02 1995-06-08 President And Fellows Of Harvard College Improved efficacy of alpha-helical cytokines
US5679338A (en) * 1994-05-12 1997-10-21 Osteoarthritis Science, Inc. Use of IL-4 for inhibition of the breakdown of articular cartilage and other tissues
US6277368B1 (en) 1996-07-25 2001-08-21 The Regents Of The University Of California Cancer immunotherapy using autologous tumor cells combined with cells expressing a membrane cytokine
CN1100566C (zh) * 1998-08-26 2003-02-05 北京师范大学 含有钙调神经磷酸酶b亚基的药物组合物
ATE278674T1 (de) * 1999-03-12 2004-10-15 Boehringer Ingelheim Pharma Heterocyklischer harnstoff und verwandte verbindungen als entzündungshemmende mittel
UA71952C2 (en) * 1999-11-16 2005-01-17 Urea aromatic derivatives as antiinflammatory agents
RU2191586C1 (ru) * 2001-05-15 2002-10-27 Ростовский научно-исследовательский онкологический институт Способ лечения рака яичников
RU2201762C1 (ru) * 2001-10-09 2003-04-10 Свадовский Александр Игоревич Способ лечения внутримозговой опухоли головного мозга
DE10321725A1 (de) * 2003-05-14 2004-12-02 Mucos Pharma Gmbh & Co Enzymhaltige Zusammensetzungen, daraus hergestellte diätetische Lebensmittel und Arzneimittel und ihre Verwendung für medizinische Zwecke
RU2389502C2 (ru) * 2004-07-29 2010-05-20 Займодженетикс, Инк. Применение il-28 и il-29 для лечения карциномы и аутоиммунных нарушений
CN100482683C (zh) * 2005-06-09 2009-04-29 中国人民解放军军事医学科学院放射与辐射医学研究所 人富含甘氨酸蛋白的活性片段及其应用
CN113368219B (zh) * 2021-06-28 2024-05-10 广东工业大学 Globulol的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4650674A (en) * 1984-07-05 1987-03-17 Genentech, Inc. Synergistic cytotoxic composition
US4770995A (en) * 1985-08-29 1988-09-13 New York Blood Center, Inc Detection of the sensitivity of cells to the effects of tumor necrosis factor and lymphotoxin
US4962091A (en) * 1986-05-23 1990-10-09 Syntex (U.S.A.) Inc. Controlled release of macromolecular polypeptides

Also Published As

Publication number Publication date
AU8950891A (en) 1992-04-28
FI931426L (fi) 1993-04-27
FI931426A0 (fi) 1993-03-30
DE69131202D1 (de) 1999-06-10
JPH06501704A (ja) 1994-02-24
CA2092914C (en) 2002-12-03
CA2092914A1 (en) 1992-04-02
IL99497A0 (en) 1992-08-18
EP0563060B1 (en) 1999-05-06
DE69131202T2 (de) 2000-01-05
SA92120509B1 (ar) 2005-11-23
NZ239829A (en) 1993-03-26
EP0563060A4 (fr) 1993-08-04
NO931139L (no) 1993-05-05
DK0563060T3 (da) 1999-11-08
KR100225322B1 (ko) 1999-10-15
ATE179617T1 (de) 1999-05-15
RU2114633C1 (ru) 1998-07-10
IE913264A1 (en) 1992-04-08
CN1053838C (zh) 2000-06-28
EP0563060A1 (en) 1993-10-06
PT99123A (pt) 1992-08-31
PT99123B (pt) 1999-02-26
ES2134200T3 (es) 1999-10-01
ZA917424B (en) 1992-05-27
GR3030930T3 (en) 1999-11-30
NO931139D0 (no) 1993-03-26
FI931426A7 (fi) 1993-04-27
AU658588B2 (en) 1995-04-27
CN1060788A (zh) 1992-05-06
WO1992005805A1 (en) 1992-04-16
JP3226918B2 (ja) 2001-11-12

Similar Documents

Publication Publication Date Title
IL99497A (en) Synergistic compositions comprising tnf and il-4
AU2563584A (en) Human cultured cell line and colony-stimulating factor produced therein
ZA844377B (en) The effect of human tumor necrosis factor and human interferon and human cancer cells and methods
IL98070A0 (en) Muteins of the granulocyte colony stimulating factor(g-csf)and pharmaceutical compositions containing them
GR3000958T3 (en) Particular compositions of rare earth oxides, their preparation and their use
NZ273258A (en) Immunomodulator composition with components less than 3000 D that are extractable from bile, stimulate monocytes and macrophages and modulate TNF
AU558901B2 (en) Method of regulating appetite and efficiency of food utilization employing interferon
RU93032615A (ru) Композиции для воздействия на опухолевые клетки, способ обработки опухолевых клеток
AU579101B2 (en) Gamma interferon - lymphotoxin synergism
ZA859894B (en) Method of using interferon in low dosage to regulate appetite and efficiency of food utilization
GB2099450B (en) High density fuel compositions
AU577906B2 (en) Mono and polycarboxylic acid amides as dispersants in fuels
AU569950B2 (en) Suppressing algal growth in solar ponds
GB2150573B (en) Leukocytic human interferon n and method to obtain it in bacterial cells
EP0437505A4 (en) Primitive cell colony stimulating factors and lymphohematopoietic progenitor cells
IL105271A0 (en) Compositions comprising tumor necrosis factor and an interferon
张金三 et al. IONIZING RADIATION-INDUCED IL-Ia, IL-6 AND GM-CSF PRODUCTION BY HUMAN LUNG CANCER CELLS
EP0088621A3 (en) Compositions for use in accelerating onset of sleep
EP0141630A3 (en) Tough, transparent lead ionomers with greater than 100% neutralization
Cassatella et al. Inducing Factor for Hematopoietic Cells
EP0497274A3 (en) Generation of adherent lak cells with interleukin-2 and interleukin-4
CA2051085A1 (en) Expression plasmids
AU530921B2 (en) Feed compositions with salinomycins
Morliere et al. Ultraviolet A radiations and the skin. Involvement of activated oxygen species. Current trends and recent findings.
Skeef et al. The Effect of Excess Zinc on cAMP Synthesis as a Regulatory Factor in Tumour Cell Proliferation

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees